Introduction
Lotel LS is a prescription medication that contains the active ingredient Loteprednol etabonate. It is available under the brand name Lotel LS. This medication is primarily used for its anti-inflammatory and immunosuppressive properties.
Uses
Lotel LS is commonly prescribed to treat various ocular conditions such as inflammation, redness, and swelling of the eye. It is particularly effective in managing post-operative inflammation following ocular surgery. Additionally, it can be used to relieve symptoms associated with allergic conjunctivitis, a condition characterized by eye itching and redness due to allergies.
Dosage and Administration
The dosage and administration of Lotel LS should be determined by your healthcare provider. It is typically applied to the affected eye(s) four times daily, or as directed by your doctor. To ensure proper administration, wash your hands thoroughly before applying the gel. Be careful not to touch the tip of the dropper bottle to any surface to avoid contamination.
Mechanism of Action
Loteprednol etabonate, the active ingredient in Lotel LS, is a corticosteroid with anti-inflammatory and immunosuppressive properties. It works by reducing inflammation and suppressing the immune response in the eye. This helps alleviate the symptoms associated with ocular conditions, such as redness, swelling, and discomfort.
Side Effects
Common side effects include temporary stinging or burning sensation upon application, blurred vision, increased sensitivity to light, and eye irritation. These side effects are usually mild and tend to resolve on their own. However, if you experience any persistent or worsening side effects, consult your healthcare provider.
Serious side effects are rare but can occur. If you experience severe eye pain, changes in vision, persistent eye redness, or signs of an allergic reaction (such as rash, itching, or swelling), seek immediate medical attention.
Drug Interactions
Lotel LS may interact with certain medications. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products. Some medications, such as certain oral corticosteroids, may increase the risk of side effects when used concomitantly with Lotel LS. Your doctor will evaluate the potential interactions and adjust your treatment plan accordingly.
Precautions
Before using Lotel LS, inform your healthcare provider about any known allergies, medical conditions, or medications you are currently taking. This medication may not be suitable for individuals with certain eye infections or conditions such as glaucoma or herpes simplex virus infection. Follow your doctor’s instructions and inform them of any changes in your medical history or current medications.
Lotel LS should not be used while wearing contact lenses. If you wear contact lenses, remove them before applying the gel and wait at least 10 minutes before reinserting them.
Storage
Patient Tips
- Follow your healthcare provider’s instructions regarding the dosage and frequency of application.
- Avoid touching the tip of the dropper bottle to any surface to prevent contamination.
- If you wear contact lenses, remove them before applying the gel and wait at least 10 minutes before reinserting them.
- If you experience any persistent or worsening side effects, contact your healthcare provider.
- Store the gel in a cool, dry place and keep it out of reach of children and pets.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Loteprednol ophthalmic (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
- loteprednol etabonate 0.2 % eye drops,suspension ophthalmic steroids (RX) [Accessed 29 Jun. 2024] (online) Available at:
- Kang C, Keam SJ, Shirley M, Syed YY. Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery. Clin Drug Investig. 2020 Apr;40(4):387-394. doi: 10.1007/s40261-020-00899-2. [Accessed 19 Jun. 2024] Available at:
- Amon M, Busin M. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Int Ophthalmol. 2012 Oct;32(5):507-17. doi: 10.1007/s10792-012-9589-2. Epub 2012 Jun 16. [Accessed 10 Jun. 2024] Available at:
Reviews
There are no reviews yet.